1. Home >
  2. Medicine Info >
  3. Mycept 500 mg Tablet

Mycept 500 mg Tablet

Manufactured by: Panacea Biotec Ltd.
Composition: Mycophenolate Mofetil
Prescription Required: Yes
More
    Contents

Description

Mycept 500 mg Tablet is a potent immunosuppressive agent. It is used along with other medicines to prevent the body from rejecting an organ transplant.

Side effects

Major & minor side effects for Mycept 500 mg Tablet

  • Constipation
  • Stomach pain or swellingsevere
  • Nausea and Vomiting
  • Trouble with sleeping
  • Pain in the arms, legs and the back
  • Uncontrolled shaking of arms or legs
  • Headache
  • Persistent diarrheasevere
  • Swelling of face, lips, eyelids, tongue, hands and feet severe
  • Severe difficulty in breathingsevererare
  • Chest pain
  • Dizziness and faintingsevere
  • Black or tarry stoolssevere
  • Bloody or coffee colored vomitsevererare
  • Yellowing of skin and eyessevererare
SEVERE
Contact your doctor immediately if any of these symptoms are experienced on a regular basis.
RARE
Observed in a small fraction of population.
This is not an exhaustive list of side effects. Please inform your doctor if you experience any adverse reaction to the medication.

Highlights

Commonly asked questions for Mycept 500 mg Tablet

Onset of action

The amount of time required for this medicine to show its effect is subject to variations based on the intended use and route of administration.

Duration of effect

The amount of time for which this medicine remains effective is subject to variations based on the intended use and route of administration.

Safe with alcohol?

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Is it habit forming?

No habit forming tendencies were reported.

Usage in pregnancy?

This medicine is not recommended for use in pregnant women unless absolutely necessary and the potential benefits heavily outweigh the risks involved. The risks are significantly higher in the first trimester. Your doctor will determine the best course of treatment based on your clinical condition.

Usage while breast-feeding?

This medicine is not recommended for use in breastfeeding women. If the use of this medicine is absolutely necessary, then your doctor may ask you to discontinue breastfeeding.

Substitutes

List of substitutes for Mycept 500 mg Tablet

Below is the list of medicines, which have the same composition, strength and form as Mycept 500 mg Tablet, and hence can be used as its substitute.
Baxmune 500 mg Tablet
Ranbaxy Laboratories Ltd.
Emcept 500 mg Tablet
Emcure Pharmaceuticals Ltd.
Mycofit 500 mg Tablet
Intas Pharmaceuticals Ltd.
Renodapt 500 mg Tablet
Biocon Ltd.
Fenograf 500 mg Tablet
Torrent Pharmaceuticals Ltd.

What is it prescribed for?

Uses of Mycept 500 mg Tablet

  • Prevention of organ transplant rejection

    This medicine is used to prevent the rejection of an organ transplant.

Find a doctor near you

Looking for a doctor?

Book an appointment with the top doctors near you.

When not to use?

Contraindications of Mycept 500 mg Tablet

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to mycophenolate or any other inactive ingredients present along with it.
  • Pregnancy

    This medicine is not recommended for use in pregnant women since the risk of miscarriage or birth defects is significantly high. Contact your doctor immediately if you suspect a pregnancy while taking this medicine. Appropriate means of birth control should be adopted while taking this medicine.

Dosage

  • Missed Dose

    The likelihood of missing an injectable dose is less since it is normally administered in a clinical setup. Take the missed oral dose as soon as you remember it. If it is almost time for the next scheduled dose, then it is advisable to skip the missed dose. Do not double the dose to make up for the missed one.
  • Overdose

    Contact your doctor if an overdose of this medicine is suspected.

Interactions

All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.

Interaction with Alcohol

  • Description

    - Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Instructions

    - Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Interaction with Medicine

  • Omeprazolemoderate
  • Sevelamermoderate
  • Ethinyl Estradiolsevere
  • Leflunomidesevere
  • Amoxicillin and Clavulanic Acidmoderate
  • Live vaccinessevere
  • Adalimumabsevere
  • Aluminium Hydroxide/Magnesium Hydroxide/Calcium carbonatemoderate

Disease interactions

  • Peptic ulcer disease

    moderate
    This medicine should be used with caution in patients suffering from peptic ulcer disease due to the increased risk of worsening of the patient's condition. Your doctor will schedule the uptake of medicines in such a way that adverse effects are minimized.
  • Kidney Disease

    moderate
    This medicine should be used with caution in patients with kidney diseases. Appropriate dose adjustments should be done based on the level of creatinine clearance. Use of this medicine is not recommended in patients with a severe renal disease.

Food interactions

  • Information not available.

Lab interactions

  • Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.

General Instructions

Take Mycept 500 mg Tablet exactly as prescribed by the doctor. It is strongly advised to take this medicine under the supervision of a doctor with frequent monitoring of blood cell count and status of the transplant acceptance by the immune system. Avoid inhalation or contact with the skin. Contact your doctor immediately if you develop signs or symptoms of an infection.

Warnings

Warnings for special population

  • Pregnancy

    - This medicine is not recommended for use in pregnant women unless absolutely necessary and the potential benefits heavily outweigh the risks involved. The risks are significantly higher in the first trimester. Your doctor will determine the best course of treatment based on your clinical condition.
  • Breast-feeding

    - This medicine is not recommended for use in breastfeeding women. If the use of this medicine is absolutely necessary, then your doctor may ask you to discontinue breastfeeding.

General warnings

  • Lesch-Nyhan/Kelley-Seegmiller syndrome

    - This medicine is not recommended for use in patients suffering from this rare genetic disorder caused by the deficiency of hypoxanthine-guanine phosphoribosyl transferase (HGPRT) enzyme.
  • Women of childbearing age

    - Women of childbearing age should take appropriate precautionary measures to avoid pregnancy while taking this medicine. It is advised to undergo a serum/urine pregnancy test prior to taking this medicine.
  • Live vaccine

    - Vaccination with live and attenuated strains of microorganisms should be avoided while taking this medicine since the risk of severe infections is significantly high.
  • Intravenous injection

    - Intravenous route of administration should be used for patients unable to take the oral form. The intravenous form should be administered as a slow infusion over a period of 2 hours.
  • Skin Cancer

    - Patients should avoid direct exposure to sunlight or sunlamps while taking this medicine due to the increased risk of skin cancer. Appropriate precautionary measures such as protective clothing, sunglasses, and sunscreen should be taken while stepping out.
  • Infections

    - Use of this medicine suppresses the immune system of patients and increases the risk of infections and sepsis.
  • Blood cell count

    - Use of this medicine may affect the count of blood cells and cause associated complications. It should be used with extreme caution in patients having blood cell disorders such as anemia, neutropenia, etc. Symptoms like fever, chills, diarrhea, unexpected bruising and bleeding should be reported to the doctor on priority. Close monitoring of complete blood cell count may be necessary based on the clinical condition of the patient.
  • Gastrointestinal disturbances

    - Use of this medicine may cause ulcers and bleed in the gastrointestinal tract. This risk is especially higher in patients with a previous history of gastrointestinal diseases. It is advised that you should inform the doctor about all your medical conditions before receiving this medicine.
  • Other medicines

    - Report the use of all medicines including vaccinations, herbs, and supplements to the doctor before receiving Mycept 500 mg Tablet to rule out chances of a possible interaction.
  • Other variants

    - The effect of mycophenolate mofetil is different from mycophenolic acid and hence patients or healthcare providers should stick to the medicine prescribed by the doctor.

Other details

  • To be taken on an empty stomach
  • To be taken as instructed by doctor
  • Does not cause sleepiness

How it works

This medicine works by suppressing the immune system which is primarily responsible for organ rejection after a transplant has been completed.

Legal Status

Approved
Approved
Approved
Approved

Classification

Category
Selective immunosuppressants
Schedule
Schedule H

References

  • [Internet]. 2017 [cited 9 August 2017]. Available from: https://davisplus.fadavis.com/3976/meddeck/pdf/mycophenolate.pdf
  • [Internet]. 2017 [cited 9 August 2017]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/050722s021,050723s019,050758s019,050759s024lbl.pdf
  • [Internet]. 2017 [cited 9 August 2017]. Available from: http://www.medsafe.govt.nz/profs/Datasheet/c/Cellceptcapsuspinf.pdf
  • DailyMed - Mycophenolate mofetil - Mycophenolate mofetil tablet, film coated Mycophenolate mofetil - mycophenolate mofetil capsule [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 9 August 2017]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=209efe01-7908-46e4-a964-0665078c0acd
  • mycophenolate mofetil [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 9 August 2017]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/5281078#section=Top
  • Mycophenolate: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 9 August 2017]. Available from: https://medlineplus.gov/druginfo/meds/a601081.html

Related Questions

  • Question:

    I am taking wysolene .5 mg, mycept s 360 i want to know is there any reaction to our body as my family member is complaining that i am getting angry because of medicines. Can this

    Answer from Dr. Sandeep Kodali

    First of all, you did not mention why you are taking wysolone daily. Unless it is indicated, you should not take wysolon

  • Question:

    I'm a  kidney transplanted patient and  my weight is increasing day to day. I'm taking prednisolone 10 mg , cyclosporine and mycept. Please tell me how to reduce my weight.

    Answer from Dr. Prashant C Dheerendra

    Dear Sir, weight gain after kidney transplant because of improvement in appetite and steroid use to prevent rejectio

  • Question:

    I am taking medicines mycept 360, hcqs 200,wysolene .7mg, pregalin sr 75, and i am increasing weight, as well my belly is coming out very fast. I am worried what should i do..dr to

    Answer from Ms. Rekha Sachdev Pohani

    With steriod also if u have healthy diet u can control weight gain.what is your height and weight.plz connect to get cus

Chat with a doctor

Get reply within 5 mins

How will this medicine affect me?

Chat with verified doctors starting @ ₹99

Did you find this helpful?

Your feedback will help us improve the product

Thanks for your response
What can we improve?
Thanks for your response
Information on this page was last updated on 11 Aug 2017

Report an error

Oops! Seems like there is an error in your form. Make sure -
  1. Your email ID is correct.
  2. Your response is not blank.
  3. Your internet is working.
Thank you!
Your response is valuable to us.

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.